|
|
||||||||
ORIGINAL ARTICLE |
1 Institute of Pharmacology & Toxicology and
2 Dept of Pulmonary Diseases, Medical Polyclinic, University of Bonn, Germany
* To whom correspondence should be addressed. E-mail: racke.kurt{at}uni-bonn.de.
| Abstract |
|---|
Clinical observations indicate that in COPD patients the long-acting muscarinic antagonist tiotropium delays decline in airway function suggesting that cholinergic mechanisms contribute to long-term structural changes. Human lung fibroblasts express muscarinic receptors and the present study aimed to explore their role in controlling collagen synthesis.
MRC-5, HEL-299 and primary human lung fibroblasts (phLFb) were cultured and incorporation of [3H]-proline into cellular proteins was determined as measure of collagen synthesis.
In MRC-5 cells the muscarinic agonist carbachol enhanced [3H]-proline incorporation in a concentration dependent manner (EC50: 220 nM, increase at 10 µM by 40–55%, in different series of experiments). Likewise, 10 µM oxotremorine caused an increase by about 65%. For comparison, TGF-ß1 (5 ng·ml-1) caused an increase by about 80%. Effects of carbachol on total [3H]-proline incorporation and collagenase-sensitive [3H]-proline fraction were similar. The effect of 10 µM carbachol was inhibited by tiotropium (IC50: 110 pM), prevented by pertussis toxin and the MAP kinase inhibitor PD 98059. Muscarinic agonists enhanced [3H]-proline incorporation in a tiotropium-sensitive manner also in HEL-299 cells and phLFb.
In human lung fibroblasts muscarinic receptors exert stimulatory effects on collagen synthesis. Prolonged blockade of muscarinic-induced collagen synthesis may contribute to reported long-term beneficial effects of anticholinergics in COPD.
Keywords: Airway remodelling, collagen synthesis, lung fibroblasts, MAP kinase, Muscarinic receptors, tiotropium
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |